3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Bronchial Neoplasms
1
Interventions
Pemetrexed
3
Carboplatin
3
pembrolizumab
2
patritumab
1
osimertinib
1
napabucasin
1
camrelizumab
1
aflutinib
1
Vinorelbine
1
TNFSF10 protein, human
1
Paclitaxel
1
Injections
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bronchial Neoplasms
×
patritumab
×
Clear all
NCT02134015
2018-01-23
HER3-Lung
Daiichi Sankyo
Phase 3
Terminated
145 enrolled
20 charts